Literature DB >> 21223965

Chemokines in health and disease.

Dayanidhi Raman1, Tammy Sobolik-Delmaire, Ann Richmond.   

Abstract

Chemokines and their receptors play a key role in development and homeostasis as well as in the pathogenesis of tumors and autoimmune diseases. Chemokines are involved in the implantation of the early conceptus, the migration of subsets of cells during embryonic development, and the overall growth of the embryo. Chemokines also have an important role in the development and maintenance of innate and adaptive immunity. In addition, they play a significant role in wound healing and angiogenesis. When the physiological role of chemokines is subverted or chronically amplified, disease often follows. Chemokines are involved in the pathobiology of chronic inflammation, tumorigenesis and metastasis, as well as autoimmune diseases. This article reviews the role of chemokines and their receptors in normal and disease processes and the potential for using chemokine antagonists for appropriate targeted therapy. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21223965      PMCID: PMC3063402          DOI: 10.1016/j.yexcr.2011.01.005

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  218 in total

1.  The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration.

Authors:  Hui-Hsin Tsai; Emma Frost; Vivien To; Shenandoah Robinson; Charles Ffrench-Constant; Robert Geertman; Richard M Ransohoff; Robert H Miller
Journal:  Cell       Date:  2002-08-09       Impact factor: 41.582

Review 2.  Chemokines: key players in innate and adaptive immunity.

Authors:  Clemens Esche; Cristiana Stellato; Lisa A Beck
Journal:  J Invest Dermatol       Date:  2005-10       Impact factor: 8.551

3.  CXCR4 and Gab1 cooperate to control the development of migrating muscle progenitor cells.

Authors:  Elena Vasyutina; Jürg Stebler; Beate Brand-Saberi; Stefan Schulz; Erez Raz; Carmen Birchmeier
Journal:  Genes Dev       Date:  2005-09-15       Impact factor: 11.361

4.  Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferation and migration.

Authors:  Adriana Bajetto; Federica Barbieri; Alessandra Dorcaratto; Simone Barbero; Antonio Daga; Carola Porcile; Jean Louis Ravetti; Gianluigi Zona; Renato Spaziante; Giorgio Corte; Gennaro Schettini; Tullio Florio
Journal:  Neurochem Int       Date:  2006-04-18       Impact factor: 3.921

5.  CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells.

Authors:  Rongcun Yang; Zhong Cai; Yuan Zhang; William H Yutzy; Katherine F Roby; Richard B S Roden
Journal:  Cancer Res       Date:  2006-07-01       Impact factor: 12.701

6.  Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape.

Authors:  Oriana Simonetti; Gaia Goteri; Guendalina Lucarini; Alessandra Filosa; Tiziana Pieramici; Corrado Rubini; Graziella Biagini; Annamaria Offidani
Journal:  Eur J Cancer       Date:  2006-04-27       Impact factor: 9.162

7.  Neuroanatomical distribution of CXCR4 in adult rat brain and its localization in cholinergic and dopaminergic neurons.

Authors:  Ghazal Banisadr; Philippe Fontanges; France Haour; Patrick Kitabgi; William Rostène; Stéphane Mélik Parsadaniantz
Journal:  Eur J Neurosci       Date:  2002-11       Impact factor: 3.386

8.  CXCR4 is a major chemokine receptor on glioma cells and mediates their survival.

Authors:  Yan Zhou; Peter H Larsen; Chunhai Hao; V Wee Yong
Journal:  J Biol Chem       Date:  2002-10-17       Impact factor: 5.157

9.  A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia.

Authors:  Ralf K Stumm; Jutta Rummel; Vera Junker; Carsten Culmsee; Manuela Pfeiffer; Josef Krieglstein; Volker Höllt; Stefan Schulz
Journal:  J Neurosci       Date:  2002-07-15       Impact factor: 6.167

10.  A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development.

Authors:  Jennifer M Burns; Bretton C Summers; Yu Wang; Anita Melikian; Rob Berahovich; Zhenhua Miao; Mark E T Penfold; Mary Jean Sunshine; Dan R Littman; Calvin J Kuo; Kevin Wei; Brian E McMaster; Kim Wright; Maureen C Howard; Thomas J Schall
Journal:  J Exp Med       Date:  2006-08-28       Impact factor: 14.307

View more
  126 in total

Review 1.  Into the eye of the cytokine storm.

Authors:  Jennifer R Tisoncik; Marcus J Korth; Cameron P Simmons; Jeremy Farrar; Thomas R Martin; Michael G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2012-03       Impact factor: 11.056

Review 2.  Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring.

Authors:  Peter Adam Rees; Nicholas Stuart Greaves; Mohamed Baguneid; Ardeshir Bayat
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

3.  [68Ga-pentixafor PET: clinical molecular imaging of chemokine receptor CXCR4 expression in multiple myeloma].

Authors:  M Avanesov; M Karul; T Derlin
Journal:  Radiologe       Date:  2015-10       Impact factor: 0.635

4.  Secretion of wound healing mediators by single and bi-layer skin substitutes.

Authors:  Manira Maarof; Jia Xian Law; Shiplu Roy Chowdhury; Khairul Anuar Khairoji; Aminuddin Bin Saim; Ruszymah Bt Hj Idrus
Journal:  Cytotechnology       Date:  2016-01-14       Impact factor: 2.058

5.  Higher circulating levels of chemokine CCL20 in patients with multiple sclerosis: evaluation of the influences of chemokine gene polymorphism, gender, treatment and disease pattern.

Authors:  A Jafarzadeh; S Bagherzadeh; H A Ebrahimi; H Hajghani; M R Bazrafshani; A Khosravimashizi; M Nemati; F Gadari; A Sabahi; F Iranmanesh; M M Mohammadi; H Daneshvar
Journal:  J Mol Neurosci       Date:  2014-01-07       Impact factor: 3.444

Review 6.  Building the posterior lateral line system in zebrafish.

Authors:  Ajay B Chitnis; Damian Dalle Nogare; Miho Matsuda
Journal:  Dev Neurobiol       Date:  2012-03       Impact factor: 3.964

7.  Nitric oxide functions in stromal cell-derived factor-1-induced cytoskeleton changes and the migration of Jurkat cells.

Authors:  Jixian Luo; Dan Wei; Dingyun Li; Lan Wang
Journal:  Oncol Lett       Date:  2018-09-11       Impact factor: 2.967

8.  Effects of exercise on leukocytosis and blood hemostasis in 800 healthy young females and males.

Authors:  Kristin L Sand; Torun Flatebo; Marian Berge Andersen; Azzam A Maghazachi
Journal:  World J Exp Med       Date:  2013-02-20

9.  Ranibizumab is a potential prophylaxis for proliferative vitreoretinopathy, a nonangiogenic blinding disease.

Authors:  Steven Pennock; David Kim; Shizuo Mukai; Matthew Kuhnle; Dal W Chun; Joanne Matsubara; Jing Cui; Patrick Ma; David Maberley; Arif Samad; Robert J Van Geest; Sarit L Oberstein; Reinier O Schlingemann; Andrius Kazlauskas
Journal:  Am J Pathol       Date:  2013-04-09       Impact factor: 4.307

Review 10.  CXCR2: a target for pancreatic cancer treatment?

Authors:  Kathleen M Hertzer; Graham W Donald; O Joe Hines
Journal:  Expert Opin Ther Targets       Date:  2013-02-21       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.